<?xml version="1.0" encoding="UTF-8"?>
<p>The fruits, seeds and callus of 
 <italic>Momordica charantia</italic> contain some insulin-like proteins [
 <xref rid="B49-biology-09-00252" ref-type="bibr">49</xref>] which are homologous to human insulin, and it produced consistent hypoglycemic effect when tested on rats, gerbils, langurs and human beings [
 <xref rid="B50-biology-09-00252" ref-type="bibr">50</xref>]. In India and China, MC was believed to be a treatment for diabetes mellitus for thousands of years. Nowadays, scientists have done many types of research focusing on its anti-hyperglycemic abilities. Indeed, many research papers have shown that its bioactivities decrease significantly in blood glucose levels (
 <xref ref-type="fig" rid="biology-09-00252-f004">Figure 4</xref>). These investigations on bitter melon also demonstrated that it can enhance the glucose tolerance of normal and diabetic mice and also in humans [
 <xref rid="B47-biology-09-00252" ref-type="bibr">47</xref>,
 <xref rid="B48-biology-09-00252" ref-type="bibr">48</xref>,
 <xref rid="B49-biology-09-00252" ref-type="bibr">49</xref>,
 <xref rid="B50-biology-09-00252" ref-type="bibr">50</xref>,
 <xref rid="B51-biology-09-00252" ref-type="bibr">51</xref>]. Many studies proved that bioactive constituents for MC have considerable antidiabetic activities (
 <xref rid="biology-09-00252-t001" ref-type="table">Table 1</xref>).
</p>
